A Cell Cycle Progression-Derived Gene Signature to Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma

CONCLUSION: Collectively, CCP-derived gene signature was a promising marker in prediction of survival outcomes and therapeutic responses for HCC patients.PMID:34721731 | PMC:PMC8553501 | DOI:10.1155/2021/1986159
Source: Disease Markers - Category: Laboratory Medicine Authors: Source Type: research